BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  MAIA Biotechnology Announces $736,600 Private Placement

  October 14, 2025

   · 

  4 min read
• Press Releases

  Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - October 13, 2025

  October 14, 2025

   · 

  1 min read
• Press Releases

  Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 14, 2025

   · 

  1 min read
• Press Releases

  Pyxis Oncology to Present Translational Data and Key Biology Findings Elucidating the Mechanism of Action of MICVO at Upcoming Medical Meetings

  October 14, 2025

   · 

  9 min read
• Press Releases

  Zentalis Pharmaceuticals Announces Four Azenosertib Posters Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 14, 2025

   · 

  7 min read
• Press Releases

  BBOT Announces Poster Presentations at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 14, 2025

   · 

  1 min read
• Press Releases

  PMV Pharmaceuticals to Present Rezatapopt Pivotal Phase 2 Initial Analysis and Natural History Study Results at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  October 14, 2025

   · 

  3 min read
• Press Releases

  Denali Therapeutics Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome)

  October 14, 2025

   · 

  6 min read
• Press Releases

  Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

  October 14, 2025

   · 

  7 min read
• Press Releases

  Avantor® Announces Board Chairman Transition

  October 14, 2025

   · 

  4 min read